The Destiny Board comprises figures drawn from the pharmaceutical and financial industries.
With many years of experience in drug development and commercialisation, the Destiny directors possess the expertise required to successfully manage the company and develop its portfolio of products.
Dr. Bill Love is Chief Executive Officer of Destiny Pharma. With 15 years of pharmaceutical industry research and development experience, Bill founded Destiny Pharma in 1997. Through his leadership the company has established an enviable research portfolio.
The other Directors are:
Peter Morgan (Director of Business Strategy)
David Scott (Commercial Director)
Joe Eagle (Non-executive)
Howard Matthews (Non-executive)
Experience and expertise
Destiny is supported by an International Scientific Development and Advisory Board, comprised of leading experts in the fields of microbiology, infection control, infectious diseases and drug development. This ensures that Destiny’s development programme is of the highest scientific quality and is designed to meet the existing and future needs of clinicians worldwide.